<DOC>
	<DOCNO>NCT01573351</DOCNO>
	<brief_summary>The purpose study ass efficacy , determine proportion subject Sustained Virologic Response Post-Treatment Week 12 ( SVR12 ) , define Hepatitis C virus ( HCV ) Ribonucleic acid ( RNA ) &lt; Limit quantitation ( LOQ ) post-treatment Week 12 .</brief_summary>
	<brief_title>Phase III Hallmark QUAD : ASV+DCV+Peg+Rib ( Nulls/Partials )</brief_title>
	<detailed_description>- ASV = Asunaprevir ( BMS-650032 ) - DCV = Daclatasvir ( BMS-790052 ) - Peg = Peg-interferon Alfa-2a ( PegIFN ) - Rib = Ribavirin ( RBV )</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<criteria>Males female , ≥ 18 year age HCV Genotype 1 4 previously fail treatment Peginterferon alfa2a peginterferon alfa2b Ribavirin ( P/R ) , classify previous null partial responder base previous therapy HCV RNA ≥ 10,000 IU/mL Seronegative Human immunodeficiency virus ( HIV ) Hepatitis B surface antigen ( HBsAg ) Subjects compensated cirrhosis permit ( compensated cirrhotics cap approximately 25 % treated population ) Prior treatment HCV HCV direct act antiviral ( DAA ) Evidence medical condition contribute chronic liver disease HCV Evidence decompensated liver disease include , limited , history presence ascites , bleed varix , hepatic encephalopathy Diagnosed suspected hepatocellular carcinoma malignancy Uncontrolled diabetes hypertension Total bilirubin ≥ 34 μmol/L ( ≥ 2 mg/dL ) unless subject documented history Gilbert 's disease Alanine aminotransferase ( ALT ) ≥ 5x Upper limit normal ( ULN ) Albumin &lt; 3.5 g/dL ( 35 g/L ) Alpha Fetoprotein ( AFP ) &gt; 100 ng/mL ( &gt; 82.6 IU/mL ) ≥ 50 ≤ 100 ng/mL require liver ultrasound subject find suspicious Hepatocellular carcinoma ( HCC ) exclude Absolute neutrophil count ( ANC ) &lt; 1.5 x 1000,000,000 cells/L ( &lt; 1.2 x 1000,000,000 cells/L Black/AfricanAmericans ) Platelets &lt; 90 x 1000,000,000 cells/L Hemoglobin &lt; 12 g/dL female &lt; 13 g/dL male Any criterion would exclude subject receive P/R</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>